表紙:ニキビ治療薬の世界市場:業界動向、シェア、市場規模、成長率、機会、予測(2021年~2026年)
市場調査レポート
商品コード
1029115

ニキビ治療薬の世界市場:業界動向、シェア、市場規模、成長率、機会、予測(2021年~2026年)

Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 147 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.01円
ニキビ治療薬の世界市場:業界動向、シェア、市場規模、成長率、機会、予測(2021年~2026年)
出版日: 2021年09月16日
発行: IMARC Services Private Limited
ページ情報: 英文 147 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のニキビ治療薬の市場規模は、2020年に48億2000万米ドルに達し、2021年から2026年の間に4.4%のCAGRで成長すると予測されています。

尋常性座瘡(にきび)などの皮膚関連疾患の増加は、市場の成長を促す重要な要因の一つです。さらに、高級スキンケア製品を使用することの利点に関する大衆の意識の高まりが、市場の成長を後押ししています。さらに、副作用が少なく、高い可能性を秘めた効果的な治療法や代替治療法の開発によって市場は牽引されています。

天然成分を使用した製品に対する消費者の嗜好が高まっていることも、成長を促す要因の一つとなっています。消費者の支出能力の向上や、ユーザーの肌タイプに合わせてカスタマイズしたニキビ治療薬を提供するオンライン小売プラットフォームの急増など、その他の要因により、市場の見通しは明るいものになると予想されます。

当レポートでは、世界のニキビ治療薬市場について調査し、市場の概要・実績・COVID-19の影響、種類別・治療薬クラス別・治療薬タイプ別・投与経路別・地域別の市場分析、競合情勢、主要企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のニキビ治療薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響

第6章 市場セグメンテーション:種類別

  • コメドナル
  • 炎症性
  • 嚢胞性
  • 術後/創傷

第7章 市場セグメンテーション:治療薬クラス別

  • レチノイド
  • 抗生物質
  • ホルモン剤
  • 複合薬
  • その他

第8章 市場セグメンテーション:治療薬タイプ別

  • OTC薬
  • 処方薬

第9章 市場セグメンテーション:投与経路別

  • 局所投与
  • 経口投与
  • 注射

第10章 市場セグメンテーション:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 国別市場内訳

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Allergan Plc
    • Bausch Health Companies Inc.
    • Bayer Aktiengesellschaft
    • Cipher Pharmaceuticals Inc.
    • Galderma Holding SA
    • Johnson & Johnson
    • Pfizer Inc.
    • Reckitt Benckiser Group Plc
    • Skinvisible Pharmaceuticals Inc.
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
図表

List of Figures

  • Figure 1: Global: Acne Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Acne Drugs Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Acne Drugs Market: Breakup by Acne Type (in %), 2020
  • Figure 4: Global: Acne Drugs Market: Breakup by Drug Class (in %), 2020
  • Figure 5: Global: Acne Drugs Market: Breakup by Drug Type (in %), 2020
  • Figure 6: Global: Acne Drugs Market: Breakup by Route of Administration (in %), 2020
  • Figure 7: Global: Acne Drugs Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Acne Drugs Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Acne Drugs (Comedonal) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 10: Global: Acne Drugs (Comedonal) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 11: Global: Acne Drugs (Inflammatory) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Acne Drugs (Inflammatory) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Acne Drugs (Cystic) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Acne Drugs (Cystic) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Acne Drugs (Postsurgical/Wound) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Acne Drugs (Postsurgical/Wound) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Acne Drugs (Retinoids) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Acne Drugs (Retinoids) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Acne Drugs (Antibiotics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Acne Drugs (Antibiotics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Acne Drugs (Hormonal Agents) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Acne Drugs (Hormonal Agents) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Acne Drugs (Combination Drugs) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Acne Drugs (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Acne Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Acne Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Acne Drugs (OTC Drugs) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Acne Drugs (OTC Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 29: Global: Acne Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Acne Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Acne Drugs (Topical) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Acne Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Acne Drugs (Oral) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Acne Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Acne Drugs (Injectable) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Global: Acne Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: North America: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: North America: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: United States: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: United States: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: Canada: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Canada: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: Asia Pacific: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: Asia Pacific: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: China: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: China: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: Japan: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 48: Japan: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 49: India: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 50: India: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 51: South Korea: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 52: South Korea: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Australia: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: Australia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: Indonesia: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: Indonesia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: Others: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: Europe: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: Europe: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Germany: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Germany: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 63: France: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 64: France: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 65: United Kingdom: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 66: United Kingdom: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 67: Italy: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 68: Italy: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 69: Spain: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 70: Spain: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 71: Russia: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 72: Russia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 73: Others: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 74: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 75: Latin America: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 76: Latin America: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 77: Brazil: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 78: Brazil: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 79: Mexico: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 80: Mexico: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 81: Others: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 82: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 83: Middle East and Africa: Acne Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 84: Middle East and Africa: Acne Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 85: Global: Acne Drugs Industry: SWOT Analysis
  • Figure 86: Global: Acne Drugs Industry: Value Chain Analysis
  • Figure 87: Global: Acne Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Acne Drugs Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Acne Drugs Market Forecast: Breakup by Acne Type (in Million US$), 2021-2026
  • Table 3: Global: Acne Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
  • Table 4: Global: Acne Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
  • Table 5: Global: Acne Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
  • Table 6: Global: Acne Drugs Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Acne Drugs Market Structure
  • Table 8: Global: Acne Drugs Market: Key Players
目次
Product Code: SR1020F65_Report

The global acne drugs market reached a value of US$ 4.82 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Acne drugs refer to the medications used for treating a dermatological infection characterized by the inflammation in the hair follicles on skin. It is usually caused by hormonal imbalance, oily skin, accumulation of dead skin cells, bacteria, stress, inadequate intake of water and excessive consumption of sugars, salts or carbohydrates. Some of the commonly used acne drugs include topical medications, such as retinoids, salicylic and azelaic acid-based ointments and dapsone-based gels, along with antibiotics, anti-androgen agents and isotretinoin. These drugs minimize the levels of oil production in the body, speed up skin cell turnover, control acne breakouts, reduce scarring and damage to the skin and prevent inflammation.

The increasing prevalence of skin-related diseases, such as acne vulgaris, is one of the key factors driving the growth of the market. Moreover, rising awareness among the masses regarding the benefits of using premium skin care products is driving the market growth. The market is further being driven by the development of effective therapeutics and treatment alternatives with reduced side effects and high potential. Increasing consumer preference for products manufactured using natural ingredients is acting as another growth-inducing factor. Manufacturers are, therefore, developing products infused with natural herbs and organic ingredients, such as aloe vera, green tea, honey, jojoba oil and rosemary, for treating acne. Other factors, including rising expenditure capacities of consumers, along with the proliferation of online retail platforms that offer customized acne drugs according to the user's skin type, are expected to create a positive outlook for the market.

Breakup by Acne Type:

  • Comedonal
  • Inflammatory
  • Cystic
  • Postsurgical/Wound

Breakup by Drug Class:

  • Retinoids
  • Antibiotics
  • Hormonal Agents
  • Combination Drugs
  • Others

Breakup by Drug Type:

  • OTC Drugs
  • Prescription Drugs

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, Cipher Pharmaceuticals Inc., Galderma Holding SA, Johnson & Johnson, Pfizer Inc., Reckitt Benckiser Group Plc, Skinvisible Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited and Teva Pharmaceutical Industries Ltd. Key Questions Answered in This Report:

  • How has the global acne drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global acne drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the acne type?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global acne drugs market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Acne Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Acne Type

  • 6.1 Comedonal
    • 6.1.1 Market Trends
    • 6.1.3 Market Forecast
  • 6.2 Inflammatory
    • 6.2.1 Market Trends
    • 6.2.3 Market Forecast
  • 6.3 Cystic
    • 6.3.1 Market Trends
    • 6.3.3 Market Forecast
  • 6.4 Postsurgical/Wound
    • 6.4.1 Market Trends
    • 6.4.3 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Retinoids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Antibiotics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hormonal Agents
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Combination Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Drug Type

  • 8.1 OTC Drugs
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Prescription Drugs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Topical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cipher Pharmaceuticals Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Galderma Holding SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Reckitt Benckiser Group Plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Skinvisible Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sun Pharmaceutical Industries Limited
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Teva Pharmaceutical Industries Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis